Advancing Cath Lab Results with FFRangio Coronary Physiology Assessment: The ALL-RISE Study

Brief description of study

The primary objective of this trial is to test whether FFRangio®-guided treatment is noninferior to conventional pressure wire-guided treatment in patients with coronary artery disease being evaluated for percutaneous coronary intervention (PCI) with respect to major adverse cardiac events (MACE) at one year.

Clinical Study Identifier: s23-00742

ClinicalTrials.gov Identifier: NCT05893498

Principal Investigator: Louai Razzouk.

Other Investigators: Alexander Slotwiner, Boutros Karam, Atul Sharma, Anvar Babaev, George Fernaine, Nathaniel Rosso Smilowitz, Sripal Bangalore, Binita Shah, Michael J Attubato, Lori Vales Lay, Doris Chan, Claudia C Serrano-Gomez, Sunil Rao.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies